Abnormal humoral immune response to mucosal antigenic stimulation in patients with lung cancer
✍ Scribed by Alain Michils; Jean-Claude Yernault; Etienne Noel; BÉAtrice Gossart; Geneviève Servais; Jean Duchateau
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 509 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Serological screening approaches have allowed for the identification of a large number of potentially relevant tumor antigens in cancer patients. Within this group, cancer testis antigens represent promising targets for cancer immunotherapy, since they are widely expressed in a variety
Humoral immune responses against the ''Cancer-Testis'' (CT) antigen NY-ESO-1 are frequently observed in patients with NY-ESO-1 expressing tumors. This is in contrast to other known tumor antigens (TA) defined by antibody or cytotoxic T cell (CTL) reactivity, i.e., MAGE-1, MAGE-3, SSX2, Melan A, and
## Abstract __Mycobacterium tuberculosis__ bacilli are seldom demonstrated in tuberculous pleural effusion (TPE) by conventional bacteriological methods. In this study, an indirect enzyme‐linked immunosorbent assay (ELISA) was developed to detect IgG against four mycobacterial recombinant antigens
Humoral and cellular immune responses to Salmonella typhi have been studied in nine children with typhoid fever. By using dot immunobinding assay, anti-0-polysaccharide chain and antilipid A antibody titers have been evaluated during the course of the disease. Anti-0-polysaccharide chain antibody ti